A sequence-based prediction method was employed to identify three ligand-binding domains in transferrin-binding protein B (TbpB) of Neisseria meningitidis strain B16B6. Site-directed mutagenesis of residues located in these domains has led to the identification of two domains, amino acids 53 to 57 and 240 to 245, which are involved in binding to human transferrin (htf). These two domains are conserved in an alignment of different TbpB sequences from N. meningitidis and Neisseria gonorrhoeae, indicating a general functional role of the domains. Western blot analysis and BIAcore and isothermal titration calorimetry experiments demonstrated that site-directed mutations in both binding domains led to a decrease or abolition of htf binding. Analysis of mutated proteins by circular dichroism did not provide any evidence for structural alterations due to the amino acid replacements. The TbpB mutant R243N was devoid of any htf-binding activity, and antibodies elicited by the mutant showed strong bactericidal activity against the homologous strain, as well as against several heterologous tbpB isotype I strains.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC321495PMC
http://dx.doi.org/10.1128/JB.186.3.850-857.2004DOI Listing

Publication Analysis

Top Keywords

transferrin-binding protein
8
neisseria meningitidis
8
site-directed mutagenesis
8
domains led
8
domains
6
protein neisseria
4
meningitidis sequence-based
4
sequence-based identification
4
identification transferrin-binding
4
transferrin-binding site
4

Similar Publications

Background: Glaesserella parasuis (G. parasuis) is the primary agent of Glässer's disease, significantly affecting nursery and early fattening piglets. Current prophylactic measures, mainly serovar-specific bacterins administered to sows, are limited by maternal immunity, which can interfere with active immunization in piglets.

View Article and Find Full Text PDF

New prospects for Zr-immuno-PET in brain applications - Alpha-synucleinopathies.

Nucl Med Biol

November 2024

Amsterdam UMC location Vrije Universiteit Amsterdam, Dept Radiology & Nuclear Medicine, De Boelelaan 1117, Amsterdam, the Netherlands; Amsterdam Neuroscience, Brain Imaging, Amsterdam, the Netherlands. Electronic address:

Article Synopsis
  • * Background research highlights how Zr-immuno-PET imaging can effectively visualize therapeutic antibodies utilizing transferrin-mediated transport across the blood-brain barrier and emphasizes the significance of alpha-synuclein in diseases like Parkinson’s.
  • * The methodology involved conjugating antibodies with a chelator and using various analyses, including radioim
View Article and Find Full Text PDF
Article Synopsis
  • Neisseria gonorrhoeae and N. meningitidis are closely related bacteria that cause gonorrhea and bacterial meningitis, respectively, and both affect different areas of the human body.
  • Although effective vaccines exist for meningococcal disease, increasing antibiotic resistance highlights the urgent need for a vaccine against gonorrhea.
  • This study explores the effectiveness of vaccines using TbpB combined with different adjuvants in mouse models, finding that certain adjuvants enhance protection against N. gonorrhoeae and N. meningitidis, suggesting a potential for a single vaccine to protect against both pathogens.
View Article and Find Full Text PDF

is the causative agent of gonorrhea, an on-going public health problem due in part to the lack of success with efforts to develop an efficacious vaccine to prevent this sexually transmitted infection. An attractive candidate vaccine antigen because of its essential function and surface exposure, the gonococcal transferrin binding protein B (TbpB) exhibits high levels of antigenic variability which poses a significant obstacle in evoking a broadly protective vaccine composition. Here, we utilize phylogenetic information to rationally select TbpB variants for inclusion into a potential gonococcal vaccine and identify two TbpB variants that when formulated together elicit a highly cross-reactive antibody response in both rabbits and mice against a diverse panel of TbpB variants and clinically relevant gonococcal strains.

View Article and Find Full Text PDF

Effectiveness of an experimental subunit ovine respiratory vaccine in reducing pneumonia in lambs.

Can Vet J

September 2024

Dr. Joyce Van Donkersgoed Inc., Coaldale, Alberta T1M 1M3 (Van Donkersgoed); Waiau, Canterbury, New Zealand (Gardner); Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, 120 Veterinary Road, Saskatoon, Saskatchewan S7N 5E3 (Prysliak, Perez-Casal).

Background: Pneumonia is the largest cause of mortality in Canadian lambs. Currently there are no licensed ovine vaccines in Canada to reduce economic losses from this production-limiting disease.

Objective Animals And Procedure: The effectiveness of an experimental subunit leukotoxin A (LtxA) and transferrin binding protein B (TbpB) vaccine was evaluated in lambs for reduction of clinical disease in an experimental challenge study and in a controlled randomized field trial in a large commercial sheep operation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!